Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 19, 2010Innovative percutaneous aortic valve replacement system provides entry into emerging market of structural heart disease
Boston Scientific Corporation (NYSE: BSX) today announced the signing of a definitive merger agreement, under which...
-
Nov 19, 2010
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its INCEPTA™, ENERGEN™ and PUNCTUA™ cardiac resynchronization...
-
Nov 17, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that its newly acquired subsidiary, Asthmatx, Inc., was awarded the 2010 Popular Science...
-
Nov 11, 2010Company supports efforts of International Diabetes Federation to promote worldwide diabetes education and prevention
Boston Scientific Corporation (NYSE: BSX) today announced its sponsorship of "World Diabetes Day" for the third year in a row. The campaign is led by the...
-
Nov 10, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that it will be hosting an Investor Day meeting, which will be simultaneously...
-
Nov 9, 2010Company implants its first Deep Brain Stimulation device designed to treat Parkinson's
Boston Scientific Corporation (NYSE: BSX) today announced the first implantation of its Vercise™ Deep Brain Stimulation (DBS) System as part...
-
Nov 2, 2010Two-year data presented at CHEST 2010 demonstrate ability of FDA-approved, non-drug asthma treatment to provide long-lasting symptom control
Boston Scientific Corporation (NYSE: BSX) today announced that its newly acquired subsidiary, Asthmatx, Inc., presented two-year...
-
Oct 28, 2010
Boston Scientific Corporation (NYSE: BSX) today announced the execution of a definitive agreement under which Stryker Corporation will acquire...
-
Oct 26, 2010
Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of Asthmatx, Inc. of Sunnyvale, California. The...
-
Oct 22, 2010Company's fully covered metal stent now approved for use in treating benign biliary strictures
Boston Scientific Corporation (NYSE: BSX) today announced that its WallFlex® Biliary RX Fully Covered Stent has received CE Mark approval for the treatment...